Cipla informs about press release

10 May 2021 Evaluate

Cipla has informed that it has enclosed press release dated 10th May 2021 titled ‘Cipla Enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1497.45 -23.10 (-1.52%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×